Recommendation	N for analysis	N (%) compliant	Correlation with DAS28 change at 6 months (correlation coefficient, one-sided significance)
1. Documented baseline target for treatment	152	101 (66%)	−0.12, 0.08
2. Documented target of clinical remission (clinical remission = DAS28 <2.6)	152	95 (63%)	−0.12, 0.07
3. Target of low disease activity (DAS28 >2.6 & <3.2) (LDAS)	57	6 (11%)	−0.02, 0.38
4. Informed of treatment target	152	135 (89%)	−0.15, 0.03*
5. Informed of treatment strategy	152	151 (99%)	0.04, 0.32
6. DAS28 at each visit	152	108 (71%)	−0.16, 0.02*
7. If working, functional impairment recorded at each visit	43	30 (70%)	−0.07, 0.34
8. Measure of disease activity at least every 3 months	152	103 (68%)	−0.07, 0.19
9. Change to therapy if target not met	136	83 (61%)	−0.03, 0.39